HomeZOE • ETR
add
Zoetis Inc
Previous close
€169.14
Day range
€167.32 - €170.80
Year range
€136.70 - €185.00
Market cap
80.65B USD
Avg Volume
262.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.39B | 11.02% |
Operating expense | 767.00M | 7.27% |
Net income | 682.00M | 14.43% |
Net profit margin | 28.56 | 3.07% |
Earnings per share | 1.58 | 16.18% |
EBITDA | 1.04B | 12.91% |
Effective tax rate | 20.82% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.71B | -2.28% |
Total assets | 14.36B | 1.78% |
Total liabilities | 9.12B | 1.01% |
Total equity | 5.23B | — |
Shares outstanding | 451.17M | — |
Price to book | 14.59 | — |
Return on assets | 16.13% | — |
Return on capital | 19.37% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 682.00M | 14.43% |
Cash from operations | 951.00M | 31.35% |
Cash from investing | -178.00M | 34.32% |
Cash from financing | -628.00M | -50.96% |
Net change in cash | 140.00M | 278.38% |
Free cash flow | 476.38M | 61.55% |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
14,100
